EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a competition assay to assess the in vitro fitness of dengue virus serotypes using an optimized serotype-specific qRT-PCR

Anne-Fleur Griffon, Loeïza Rault, Clément Tanvet iD, Etienne Simon-Lorière, Myrielle Dupont-Rouzeyrol, Catherine Inizan iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0339033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Anne-Fleur Griffon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dengue and Arboviruses, Research and Expertise Unit - Institut Pasteur in New Caledonia - Pasteur Network, Dumbéa-sur-Mer, New Caledonia. Hauptthemen laut MEDLINE: Dengue Virus, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Institut Pasteur, Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Comparing the in vitro fitness of dengue virus (DENV) isolates is a pivotal approach to assess the contribution of DENV strains’ replicative fitness to epidemiological contexts, including serotype replacements. Competition assays are the gold standard to compare the in vitro replicative fitness of viral strains. Implementing competition assays between DENV serotypes requires an experimental setup and an appropriate read-out to quantify the viral progeny of strains belonging to different serotypes.

Methods

In the current study, we optimized an existing serotyping qRT-PCR by adapting primer/probe design and multiplexing the serotype-specific qRT-PCR reactions, allowing to accurately detect and quantify all four DENV serotypes. We next developed an in vitro competition assay to compare the replicative fitness of two DENV serotypes in the human hepatic cell line HuH7.

Findings

The qRT-PCR was specific, and had a limit of detection below 7.52, 1.19, 3.48 and 1.36 genome copies/µL, an efficiency of 1.993, 1.975, 1.902, 1.898 and a linearity (R²) of 0.99975, 0.99975, 0.99850, 0.99965 for DENV-1, −2, −3 and −4, respectively. Challenge of this multiplex serotype-specific qRT-PCR on mixes of viral supernatants containing known concentrations of strains from two serotypes evidenced an accurate quantification of the amount of genome copies of each serotype. Quantification of the viral progeny of each serotype in the inoculum and the supernatant of competition assays using the serotype-specific multiplex qRT-PCR unveiled an enrichment of the supernatant in DENV-1 genome copies, uncovering the enhanced replicative fitness of this DENV-1 isolate.

Conclusions

This optimized qRT-PCR combined with a relevant cellular model allowed to accurately quantify the viral progeny of two DENV strains belonging to two different serotypes in a competition assay, allowing to determine which strain had a replicative advantage. This reliable experimental setup is adaptable to the comparative study of the replicative fitness of any DENV serotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dengue VirusReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionHumansSerogroupSerotypingVirus ReplicationCell LineRNA, ViralDengue

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Dengue and Arboviruses, Research and Expertise Unit - Institut Pasteur in New Caledonia - Pasteur Network, Dumbéa-sur-Mer, New Caledonia.
  • Evolutionary genomics of RNA viruses Unit, Institut Pasteur, Université Paris Cité, CNRS UMR2000, Paris, France.

ORCID-Profile: Clément Tanvet, Catherine Inizan

Förderung

  • NIAID NIH HHS
  • Institut Pasteur
  • Agence Nationale de la Recherche
  • Fondation Ledoux - Jeunesse Internationale
  • Ixcore doundation for research
  • French Government
  • HERA project DURABLE
  • National Institute of Health

Zitieren

APA

Griffon, A. F., Rault, L., Tanvet, C., Simon-Lorière, E., Dupont-Rouzeyrol, M., & Inizan, C. (2025). Development of a competition assay to assess the in vitro fitness of dengue virus serotypes using an optimized serotype-specific qRT-PCR. PLOS One. https://doi.org/10.1371/journal.pone.0339033

Vancouver

Griffon AF, Rault L, Tanvet C, Simon-Lorière E, Dupont-Rouzeyrol M, Inizan C. Development of a competition assay to assess the in vitro fitness of dengue virus serotypes using an optimized serotype-specific qRT-PCR. PLOS One. 2025. doi:10.1371/journal.pone.0339033

BibTeX
@article{Griffon2025,
  author = {Griffon, Anne-Fleur and Rault, Loeïza and Tanvet, Clément and Simon-Lorière, Etienne and Dupont-Rouzeyrol, Myrielle and Inizan, Catherine},
  title = {Development of a competition assay to assess the in vitro fitness of dengue virus serotypes using an optimized serotype-specific qRT-PCR},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0339033}
}
Kostenlos starten →